MULTI-CENTRE, OPEN-LABEL, SAFETY STUDY OF ETRIPAMIL NASAL SPRAY IN SPONTANEOUS EPISODES OF PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA

Registry ID

MSP-2017-1158 (NODE-302)

Source registry

HEALTH_CANADA

Status

Closed

Study type

INTERVENTIONAL

Sponsor

MILESTONE PHARMACEUTICALS INC

Start date

2018-12-21

Completion date

2020-10-02

Last update

2018-07-11

Conditions

• PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA (PSVT)

Related clinical trials

• MULTI-CENTER, MULTI-NATIONAL, OPEN-LABEL, EFFICACY AND SAFETY STUDY OF ETRIPAMIL NASAL SPRAY IN PEDIATRIC PATIENTS WITH PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA
• MULTI-CENTRE, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, EFFICACY, AND SAFETY STUDY OF ETRIPAMIL NASAL SPRAY FOR THE TERMINATION OF SPONTANEOUS EPISODES OF PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA

View on source registry